Literature DB >> 9681528

Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.

S C Liu1, E R Sauter, M L Clapper, R S Feldman, L Levin, S Y Chen, T J Yen, E Ross, P F Engstrom, A J Klein-Szanto.   

Abstract

The expression of several markers of epithelial cell proliferation was analyzed to establish baseline data for future chemoprevention studies of oral premalignant lesions. Punch biopsies (n = 60) from three different sites of oral mucosa (bucca, lateral tongue, and the floor of the mouth) were obtained from 20 normal donors of both sexes. After formaldehyde fixation and paraffin embedding, immunohistochemistry was used to detect the proliferation markers Mib-1, cyclin D1, and centromere-associated protein CENP-F. Analysis of sections stained for the three markers showed similar patterns, i.e., a low labeling index (LI) in the basal layer and a high LI in the parabasal layer at all three intraoral sites. No proliferative activity was seen above the parabasal layer (superficial layer). All sites showed similar Mib-1 LI values for the proliferative markers. The tongue epithelium exhibited higher parabasal LIs of cyclin D1 and CENP-F than did the other two sites. No significant differences were detected between smokers and nonsmokers. The data from normal mucosa were compared with those from low (n = 30)- and high (n = 17)-grade dysplastic leukoplakias. The Mib-1 LI showed a very significant change, with a 9-fold increase in the basal layer LI in dysplastic leukoplakias. Cyclin D1 and CENP-F showed similar trends with increments of up to 7-fold in the basal layer of high-grade dysplasia. Although the proliferative activity of the parabasal layer was similar in normal and leukoplakic epithelia, the superficial layer showed a significant increment in proliferative activity mainly in high-grade leukoplakia. These studies suggest that proliferation markers in the basal and superficial cells of premalignant lesions may serve as surrogate end point biomarkers for chemoprevention trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681528

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry.

Authors:  Xiaoyan Shi; Xianglin Yuan; Deding Tao; Jianping Gong; Guoqing Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

Authors:  Sallyann L O'Brien; Ailís Fagan; Edward J P Fox; Robert C Millikan; Aedín C Culhane; Donal J Brennan; Amanda H McCann; Shauna Hegarty; Siobhan Moyna; Michael J Duffy; Desmond G Higgins; Karin Jirström; Göran Landberg; William M Gallagher
Journal:  Int J Cancer       Date:  2007-04-01       Impact factor: 7.396

3.  Association of TGFβ signaling with the maintenance of a quiescent stem cell niche in human oral mucosa.

Authors:  Claudia D Andl; Grégoire F Le Bras; Holli Loomans; Annette S Kim; Linli Zhou; Yuhang Zhang; Thomas Andl
Journal:  Histochem Cell Biol       Date:  2016-08-02       Impact factor: 4.304

Review 4.  Cenp-F (mitosin) is more than a mitotic marker.

Authors:  Asta Varis; Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2006-03-25       Impact factor: 4.316

5.  Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.

Authors:  Tiepeng Xiao; Hiroshi Kurita; Tetsu Shimane; Yoshitaka Nakanishi; Takeshi Koike
Journal:  Int J Clin Oncol       Date:  2012-07-25       Impact factor: 3.402

6.  Fluorescence PCR quantification of cyclin D1 expression.

Authors:  Kojo S J Elenitoba-Johnson; Sandra D Bohling; Stephen D Jenson; Zhaosheng Lin; Kimberly A Monnin; Megan S Lim
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

7.  The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues.

Authors:  Min Xu; Yu-Lan Jin; Jun Fu; Hong Huang; Sheng-Zu Chen; Ping Qu; Hai-Mei Tian; Zhao-Yang Liu; Wei Zhang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 8.  Clinical implications of biomarkers in head and neck cancer.

Authors:  W M Koch
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

9.  Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions.

Authors:  Angela J Yoon; Jing Shen; Regina M Santella; Elizabeth M Philipone; Hui-Chen Wu; Sidney B Eisig; Andrew Blitzer; Lanny G Close; David J Zegarelli
Journal:  J Orofac Sci       Date:  2012

10.  Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21(WAF1/CIP1) dependent.

Authors:  Haiming Ding; Chunhua Han; Dongmei Guo; Dasheng Wang; Wenrui Duan; Ching-Shih Chen; Steven M D'Ambrosio
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.